激活预致敏与细胞因子多能性调控低亲和力CD19 CAR T细胞增强的功能
该研究在体外系统比较了低亲和力CAT与高亲和力FMC63 CD19 CAR T细胞在CD19刺激后的转录组(RNA测序)和蛋白质(飞行时间流式细胞术)变化;结果显示CAT CAR T细胞激活增强、细胞因子多能性增加,其增强功能源于制备过程中残留CD19阳性B细胞诱导的抗原依赖性预致敏。
要点
- 低亲和力CAT CAR T细胞在CD19刺激后激活增强,细胞因子多能性高于FMC63 CAR T细胞。
- CAT CAR T细胞的增强功能源于制备中残留CD19阳性B细胞诱导的抗原依赖性预致敏。
- 研究采用RNA测序和飞行时间流式细胞术进行体外转录组与蛋白质表征。
核心结论
- 低亲和力CAT CAR T细胞增强的功能是制备中残留CD19阳性B细胞诱导的抗原依赖性预致敏的结果。
研究设计与样本
- 对表达低亲和力与高亲和力CD19 CAR的T细胞在CD19阳性细胞刺激后进行体外转录组(RNA测序)和蛋白质(飞行时间流式细胞术)系统表征。
主要发现
- CAT CAR T细胞对CD19刺激表现出增强的激活,并具有独特的转录组和蛋白质谱。
- 与FMC63 CAR T细胞相比,CAT CAR T细胞的激活和细胞因子多能性增加。
- 低亲和力CAT CAR T细胞增强的功能是制备中残留CD19阳性B细胞诱导的抗原依赖性预致敏的结果。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We recently described a low-affinity second-generation CD19 chimeric antigen receptor (CAR) CAT that showed enhanced expansion, cytotoxicity, and antitumor efficacy compared with the high-affinity (FMC63-based) CAR used in tisagenlecleucel, in preclinical models. Furthermore, CAT demonstrated an excellent toxicity profile, enhanced in vivo expansion, and long-term persistence in a phase 1 clinical study. To understand the molecular mechanisms behind these properties of CAT CAR T cells, we performed a systematic in vitro characterization of the transcriptomic (RNA sequencing) and protein (cytometry by time of flight) changes occurring in T cells expressing low-affinity vs high-affinity CD19 CARs following stimulation with CD19-expressing cells. Our results show that CAT CAR T cells exhibit enhanced activation to CD19 stimulation and a distinct transcriptomic and protein profile, with increased activation and cytokine polyfunctionality compared with FMC63 CAR T cells. We demonstrate that the enhanced functionality of low-affinity CAT CAR T cells is a consequence of an antigen-dependent priming induced by residual CD19-expressing B cells present in the manufacture.
引用
- Michelozzi IM, Gomez-Castaneda E, Pohle RVC, et al. Activation priming and cytokine polyfunctionality modulate the enhanced functionality of low-affinity CD19 CAR T cells. Blood Adv. 2023. PMID: 36453632. doi:10.1182/bloodadvances.2022008490
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。